Table 1.
Characteristic | All patients | GDB patients |
---|---|---|
Total | 44 | 35 |
| ||
Male | 22 (50%) | 15 (43%) |
Female | 22 (50%) | 20 (57%) |
Age | ||
Median | 54.5 | 54 |
Range | 24–75 | 39–72 |
ECOG | ||
Median | 0 | 0 |
Range | 0-1 | 0-1 |
Tumor type | ||
Leiomyosarcoma | 20 (45%) | 18 (51%) |
Uterine | 5 | 5 |
Nonuterine | 15 | 13 |
Undifferentiated pleomorphic sarcoma | 17 (39%) | 11 (31%) |
Angiosarcoma (liver, bone, soft tissue) | 6 (14%) | 5 (14%) |
Pleomorphic liposarcoma | 1 (2%) | 1 (3%) |
Prior treatment | ||
Doxorubicin (or liposomal doxorubicin) | 8 | 5 |
Ifosfamide | 5 | 3 |
Dacarbazine | 3 | 2 |
Sorafenib | 2 | 1 |
None | 34 (77%) | 29 (83%) |